Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Kupper

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Molecular Cancer Therapeutics|July 22, 2017
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell LymphomaSalvia Jain, Abigail Washington, Rebecca Karp Leaf, et al.
Blood Cancer Journal|April 17, 2025
Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphomaCecilia Larocca, Ai-Tram N Bui, John T O'Malley, et al.
Molecular Cancer Therapeutics|August 8, 2012
Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cellsDe-Kuan Chang, Jianhua Sui, Shusheng Geng, et al.
The Journal of Clinical Investigation|November 15, 2011
Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphomaClara Curiel-Lewandrowski, Hisato Yamasaki, Chuan Ping Si, et al.
Cancer Immunology Research|March 13, 2020
IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant TumorsTian Tian, Serena Lofftus, Youdong Pan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2018
T-cell trafficking plays an essential role in tumor immunityDaniel J Aires, Masaru Yoshida, Stephen K Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis FungoidesJohn T O'Malley, Adele de Masson, Elizabeth L Lowry, et al.
Science Translational Medicine|January 21, 2012
Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patientsRachael A Clark, Rei Watanabe, Jessica E Teague, et al.
Cancer Research|January 8, 2011
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growthNatasha Y Frank, Tobias Schatton, Soo Kim, et al.
Nature|January 19, 2008
Identification of cells initiating human melanomasTobias Schatton, George F Murphy, Natasha Y Frank, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|July 22, 2017
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell LymphomaSalvia Jain, Abigail Washington, Rebecca Karp Leaf, et al.
Blood Cancer Journal|April 17, 2025
Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphomaCecilia Larocca, Ai-Tram N Bui, John T O'Malley, et al.
Molecular Cancer Therapeutics|August 8, 2012
Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cellsDe-Kuan Chang, Jianhua Sui, Shusheng Geng, et al.
The Journal of Clinical Investigation|November 15, 2011
Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphomaClara Curiel-Lewandrowski, Hisato Yamasaki, Chuan Ping Si, et al.
Cancer Immunology Research|March 13, 2020
IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant TumorsTian Tian, Serena Lofftus, Youdong Pan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2018
T-cell trafficking plays an essential role in tumor immunityDaniel J Aires, Masaru Yoshida, Stephen K Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis FungoidesJohn T O'Malley, Adele de Masson, Elizabeth L Lowry, et al.
Science Translational Medicine|January 21, 2012
Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patientsRachael A Clark, Rei Watanabe, Jessica E Teague, et al.
Cancer Research|January 8, 2011
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growthNatasha Y Frank, Tobias Schatton, Soo Kim, et al.
Nature|January 19, 2008
Identification of cells initiating human melanomasTobias Schatton, George F Murphy, Natasha Y Frank, et al.
Pageof 15